Brunello, Emy and Masini, Antonio (2016) NEM® Brand Eggshell Membrane Effective in the Treatment of Pain and Stiffness Associated with Osteoarthritis of the Knee in an Italian Study Population. International Journal of Clinical Medicine, 07 (02). pp. 169-175. ISSN 2158-284X
IJCM_2016022915171090.pdf - Published Version
Download (641kB)
Abstract
A single-center, open-label clinical study was conducted to evaluate the efficacy and safety of NEM® as a natural treatment for pain and stiffness associated with osteoarthritis of the knee in an Italian population. NEM® brand eggshell membrane is a unique dietary supplement that contains naturally occurring glycosaminoglycans and proteins essential for maintaining healthy joints and connective tissues. Twenty-five subjects received oral NEM®, 500 mg once daily for four weeks. The primary outcome measure was to evaluate the mean effectiveness of NEM® in relieving general pain associated with moderate osteoarthritis of the knee at 10 and 30 days utilizing a 10-question, abbreviated questionnaire based on the WOMAC osteoarthritis questionnaire. Supplementation with NEM® produced a significant treatment response from baseline at both 10 days and 30 days for composite pain (40.6% reduction, p < 0.001; 66.4% reduction, p < 0.001, respectively). There was also a statistically significant concurrent reduction in analgesic use during the 30-day study period. Additionally, a significant treatment response from baseline was also observed for composite stiffness at both 10 days and 30 days (22.2% reduction, p = 0.009; 59.7% reduction, p < 0.001, respectively). There were no adverse events or serious adverse events reported during the study and the treatment was reported to be well tolerated by study participants. NEM® is an effective and safe natural therapeutic option for the treatment of both pain and stiffness associated with osteoarthritis of the knee. Supplementation with NEM®, 500 mg taken once daily, significantly reduced both pain and stiffness rapidly (10 days) and this effect continued to improve through 30 days. There was also a meaningful reduction in the amount of analgesic consumed on a weekly basis, which further enhanced patients’ safety.
Item Type: | Article |
---|---|
Subjects: | Academic Digital Library > Medical Science |
Depositing User: | Unnamed user with email info@academicdigitallibrary.org |
Date Deposited: | 25 Jan 2023 08:57 |
Last Modified: | 17 Feb 2024 04:06 |
URI: | http://publications.article4sub.com/id/eprint/190 |